Form 4: Boxer Capital Management Sells Shares of Tango Therapeutics (TNGX)

Boxer Capital Management, a significant shareholder of Tango Therapeutics, recently sold a portion of its holdings in two transactions.

Summary

• Boxer Capital Management, LLC, along with Aaron I. Davis, filed a Form 4 detailing changes in their beneficial ownership of Tango Therapeutics, Inc. (TNGX) common stock.
• On October 21, 2024, Boxer Capital Management sold 625,000 shares at a weighted average price of $7.05 per share.
• The prices for these shares ranged from $7.0018 to $7.2372.
• On October 22, 2024, they sold an additional 250,000 shares at a weighted average price of $6.78 per share, with prices ranging from $6.7100 to $6.9050.
• Following these transactions, Boxer Capital Management directly holds 7,323,642 shares.
• Additionally, MVA Investors, LLC, holds 108,793 shares, and BCTG Holdings, LLC, holds 6,988,450 shares, in which Aaron I. Davis has indirect interests.
• Boxer Capital Management disclaims beneficial ownership of these indirectly held securities except to the extent of their pecuniary interest.
• The reporting persons may be deemed members of a group that beneficially owns more than 10% of Tango Therapeutics' outstanding shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports transactions. The sales could be interpreted negatively, but without further context, it's difficult to assess the overall impact.

Negatives

• Boxer Capital Management reduced its direct holdings in Tango Therapeutics through the sale of shares.

Risks

• Continued selling pressure from major shareholders like Boxer Capital Management could negatively impact the stock price of Tango Therapeutics.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders or major shareholders of a publicly traded company buy or sell shares. These filings provide transparency into the transactions of those with privileged information about the company.

Stakeholder Impact

• The sale of shares by a major shareholder like Boxer Capital Management could create uncertainty among other shareholders.
• The transactions may influence the short-term stock price of Tango Therapeutics.

Key Dates